ProShare Advisors’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $64.9K | Buy |
|
|||||
|
2025
Q1 | $55.9K | Sell |
|
|||||
|
2024
Q4 | $50.6K | Buy |
|
|||||
|
2024
Q3 | $44.1K | Buy |
|
|||||
|
2024
Q2 | $48.5K | Sell |
|
|||||
|
2024
Q1 | $51.5K | Buy |
|
|||||
|
2023
Q4 | $29.1K | Buy |
|
|||||
|
2023
Q3 | $13.9K | Sell |
|
|||||
|
2023
Q2 | $15.6K | Buy |
|
|||||
|
2023
Q1 | $18.3K | Sell |
|
|||||
|
2022
Q4 | $33.1K | Buy |
|
|||||
|
2022
Q3 | $48K | Sell |
|
|||||
|
2022
Q2 | $32K | Sell |
|
|||||
|
2022
Q1 | $99K | Sell |
|
|||||
|
2021
Q4 | $184K | Buy |
|
|||||
|
2021
Q3 | $127K | Sell |
|
|||||
|
2021
Q2 | $372K | Buy |
|
|||||
|
2021
Q1 | $380K | Buy |
|
|||||
|
2020
Q4 | $411K | Buy |
|
|||||
|
2020
Q3 | $159K | Sell |
|
|||||
|
2020
Q2 | $175K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $268K | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $267K | Buy |
|
|||||
|
2018
Q2 | $326K | Buy |
|